114 related articles for article (PubMed ID: 37948578)
1. Circulating serum microRNAs as biomarkers of drug resistance in multiple myeloma patients treated with bortezomib-based regimens - pilot study.
Puła A; Robak T; Dróżdż I; Stawiski K; Rycerz A; Misiewicz M; Robak P
Leuk Lymphoma; 2024 Feb; 65(2):257-264. PubMed ID: 37948578
[TBL] [Abstract][Full Text] [Related]
2. Combining plasma extracellular vesicle Let-7b-5p, miR-184 and circulating miR-22-3p levels for NSCLC diagnosis and drug resistance prediction.
Vadla GP; Daghat B; Patterson N; Ahmad V; Perez G; Garcia A; Manjunath Y; Kaifi JT; Li G; Chabu CY
Sci Rep; 2022 Apr; 12(1):6693. PubMed ID: 35461372
[TBL] [Abstract][Full Text] [Related]
3. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
4. The Relationship between Serum miRNAs and Early Mortality in Multiple Myeloma Patients Treated with Bortezomib-Based Regimens.
Puła A; Robak P; Jarych D; Mikulski D; Misiewicz M; Drozdz I; Fendler W; Szemraj J; Robak T
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769265
[TBL] [Abstract][Full Text] [Related]
5. The Value of Serum MicroRNA Expression Signature in Predicting Refractoriness to Bortezomib-Based Therapy in Multiple Myeloma Patients.
Robak P; Dróżdż I; Jarych D; Mikulski D; Węgłowska E; Siemieniuk-Ryś M; Misiewicz M; Stawiski K; Fendler W; Szemraj J; Smolewski P; Robak T
Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32916955
[TBL] [Abstract][Full Text] [Related]
6. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis.
Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y
Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985
[TBL] [Abstract][Full Text] [Related]
7. Contribution of platelet-derived microRNAs to serum microRNAs in healthy men.
Wakabayashi I; Sotoda Y; Eguchi R
Platelets; 2021 Oct; 32(7):984-987. PubMed ID: 32865089
[TBL] [Abstract][Full Text] [Related]
8. Association of recurrent venous thromboembolism and circulating microRNAs.
Wang X; Sundquist K; Svensson PJ; Rastkhani H; Palmér K; Memon AA; Sundquist J; Zöller B
Clin Epigenetics; 2019 Feb; 11(1):28. PubMed ID: 30760335
[TBL] [Abstract][Full Text] [Related]
9. Circulating miRNAs as diagnostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.
Li J; Zhang M; Wang C
J Clin Lab Anal; 2020 Jun; 34(6):e23233. PubMed ID: 32039495
[TBL] [Abstract][Full Text] [Related]
10. Serum and thyroid tissue level of let-7b and their correlation with TRAb in Graves' disease.
Chen X; Huang F; Qi Y; Zhou M; Yin Q; Peng Y; Zhou Y; Ning G; Wang S
J Transl Med; 2018 Jul; 16(1):188. PubMed ID: 29976201
[TBL] [Abstract][Full Text] [Related]
11. Plasma Circulating Mirnas Profiling for Identification of Potential Breast Cancer Early Detection Biomarkers.
Jusoh AR; Mohan SV; Lu Ping T; Tengku Din TADAAB; Haron J; Romli RC; Jaafar H; Nafi SN; Tuan Salwani TI; Yahya MM
Asian Pac J Cancer Prev; 2021 May; 22(5):1375-1381. PubMed ID: 34048164
[TBL] [Abstract][Full Text] [Related]
12. Increased MicroRNA Levels in Women With Polycystic Ovarian Syndrome but Without Insulin Resistance: A Pilot Prospective Study.
Butler AE; Ramachandran V; Cunningham TK; David R; Gooderham NJ; Benurwar M; Dargham SR; Hayat S; Sathyapalan T; Najafi-Shoushtari SH; Atkin SL
Front Endocrinol (Lausanne); 2020; 11():571357. PubMed ID: 33101204
[TBL] [Abstract][Full Text] [Related]
13. miRNA-146a-5p is upregulated in serum and cartilage samples of patients with osteoarthritis.
Skrzypa M; Szala D; Gablo N; Czech J; Pajak J; Kopanska M; Trzeciak M; Gargasz K; Snela S; Zawlik I
Pol Przegl Chir; 2019 Feb; 91(3):1-5. PubMed ID: 31243168
[TBL] [Abstract][Full Text] [Related]
14. The Effects of Regular Exercise on Circulating Cardiovascular-related MicroRNAs.
Barber JL; Zellars KN; Barringhaus KG; Bouchard C; Spinale FG; Sarzynski MA
Sci Rep; 2019 May; 9(1):7527. PubMed ID: 31101833
[TBL] [Abstract][Full Text] [Related]
15. Abnormal regulation of microRNAs and related genes in pediatric β-thalassemia.
Wang H; Chen M; Xu S; Pan Y; Zhang Y; Huang H; Xu L
J Clin Lab Anal; 2021 Sep; 35(9):e23945. PubMed ID: 34398996
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of Circulating miRNAs in Lymph Node Metastasis for Colon Cancer.
Lee IH; Kim G; Kwak SG; Baek DW; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Hur K; Kim JG
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33513887
[TBL] [Abstract][Full Text] [Related]
17. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA circ-CCT3 promotes bortezomib resistance in multiple myeloma via modulating miR-223-3p/BRD4 axis.
Liu D; Wang Y; Li H; Peng S; Tan H; Huang Z
Anticancer Drugs; 2022 Jan; 33(1):e145-e154. PubMed ID: 34387610
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA profiling in serum: Potential signatures for breast cancer diagnosis.
Zou X; Xia T; Li M; Wang T; Liu P; Zhou X; Huang Z; Zhu W
Cancer Biomark; 2021; 30(1):41-53. PubMed ID: 32894240
[TBL] [Abstract][Full Text] [Related]
20. The transcardiac gradient of cardio-microRNAs in the failing heart.
Marques FZ; Vizi D; Khammy O; Mariani JA; Kaye DM
Eur J Heart Fail; 2016 Aug; 18(8):1000-8. PubMed ID: 27072074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
